Related Image: Historical photographs expose decline in Florida's reef fish, new Scripps study finds |
(Date:12/2/2009)..., Scientists are reporting the first identificat...transformation that changes harmless marine bacter...r study appears in ACS, Environmental Science & T...n and colleagues note that bleaching already has d...fs, and scientists are searching for ways to slow ...
(Date:12/2/2009)... , Single-walled nanotubescylinders of carbon abo...for potential applications such as ultrastrong fib...rogen storage components for fuel cells. Thanks to...Institute of Standards and Technology (NIST) and f...the list: detection and destruction of an aggressi...
(Date:12/2/2009)... , (Dec. 2, 2009) HOBOKEN, NJ According to the ...cent of Americans diagnosed with diabetes already ... retinopathy, damage to the retina caused by leaky...eople with diabetes and is one of the most feared ... of all patients who,ve had diabetes for 10 years ...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3Antioxidants Pose No Melanoma Threat 54669 1Antioxidants Pose No Melanoma Threat 54669 2Antioxidants Pose No Melanoma Threat 54669 3Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 1Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 3Spherix Reports Second Quarter 2009 Earnings 13596 1Spherix Reports Second Quarter 2009 Earnings 13596 2Spherix Reports Second Quarter 2009 Earnings 13596 3Spherix Reports Second Quarter 2009 Earnings 13596 4Spherix Reports Second Quarter 2009 Earnings 13596 5Spherix Reports Second Quarter 2009 Earnings 13596 6Spherix Reports Second Quarter 2009 Earnings 13596 7Spherix Reports Second Quarter 2009 Earnings 13596 8...alo Alto, CA and New York, NY, October 30, 2008 B...therapies for autoimmune diseases, and the Juvenil...g charitable funder of type 1 diabetes research, t...ongoing Phase I/II human clinical trial of BHT-302...at causes type 1 diabetes. , BHT-3021 is an antig...
...umblebee colonies which are fast learners are also...scientists from Queen Mary, University of London a...from Queen Mary,s School of Biological and Chemica...monn Mallon from the University of Leicester teste... bumblebees from twelve colonies. , The team tes...
...fter eight years of near-zero growth in atmospheri...d to rise. , "This is not good news for future gl...-authored a paper to be published in Geophysical R...ical Union. , "Over recent years, the growth of i...CFCs, had slowed. This tended to offset the increa...
Other Biology News:Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 2Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 3Bee smart, bee healthy 2Global methane levels on the rise again 2(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCa... "Company") (TSX:ONC; NASDAQ: ONCY ) announced tod...d unit offering, the underwriters have exercised i...n additional 637,500 units. Each unit is comprised...chase warrant, and was sold at a price of US$3.00 ...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /...bility study evaluating the preclinical (animal st... which combines technology from Weill,Cornell Medi...potential to,treat inherited anemias such as Coole... series of technologies to expand, ex vivo,popula...
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/...) (the "Company"), a global biopharmaceutical comp...ay announced that the U.S. Food and Drug Administr... the Company,s PI3K/Akt pathway inhibitor compound...psed/refractory multiple myeloma. Keryx Biopharmac...
(Date:12/1/2009)... Dr. Kerry Solomon announced ... has launched his redesigned website at www.DrKer...sulting Group. Dr. Solomon is a proven LASIK, len...n professionally recognized for his substantial co.... He is a member of Trusted LASIK Surgeons, which...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6..., March 31 Sigma-Aldrich (Nasdaq: SIAL ) toda...rvices and oligonucleotides to Gene Oracle, an inn...f the agreement, Sigma-Aldrich will be the exclusi...acle, and the two Companies will engage in co-mark...eir expert gene synthesis services ( http://www....
...elix Consulting US, a division of London-based Dou...ppointment of Ann Stuchiner to the position of Vic...team of highly experienced strategic pricing, reim...sive experience across the healthcare industry, wh...firms in the pharmaceutical, biotechnology and med...
... Medical Innovations, Inc. (NYSE: IMA ), a globa... their health at home through the merger of rapid ...dividend of $3.00 per share on its Series B Conver...e dividend will be paid in shares of Series B stoc...(a) $3.00 divided by (b) 97% of the average of the...
Other Biology Technology:Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 3Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division 2...cultured in Ham's F12K medium with 2 mM L-glutamin...er to keep the antigens in their native forms, cel...rrayed on a 12-well (5 mm) adhesive coated slide, ...hance cellular attachment and to minimize backgrou...
BD Falcon cultivation flask from BD Biosciences - Discovery Labware
Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate
...ecifically for western blots ,• Optically c...ly designed for staining western blots. The reduce...quires less dye and antibodies resulting in a sign...ach corner facilitate pouring of liquid. Optically...
Biology Products: